atracurium has been researched along with Oculopharyngeal Dystrophy in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boudreault, D; Brais, B; Caron, MJ; Chouinard, P; Duranceau, A; Girard, DC; Girard, F; Nassif, E; Ruel, M | 1 |
1 trial(s) available for atracurium and Oculopharyngeal Dystrophy
| Article | Year |
|---|---|
Cisatracurium pharmacodynamics in patients with oculopharyngeal muscular dystrophy.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, General; Atracurium; Female; Humans; Male; Middle Aged; Muscular Dystrophy, Oculopharyngeal; Neuromuscular Nondepolarizing Agents; Synaptic Transmission | 2005 |